Exploiting features of adenovirus replication to support mammalian kinase production

Faced with the current wealth of genomic data, it is essential to have robust and reliable methods of converting DNA sequences into their functional gene products. We demonstrate here that when conditions are established that take advantage of the replication‐associated virus amplification, the viru...

Full description

Saved in:
Bibliographic Details
Published inNucleic acids research Vol. 31; no. 21; p. e128
Main Authors Cotten, Matt, Stegmueller, Kerstin, Eickhoff, Jan, Hanke, Miriam, Herzberger, Katrin, Herget, Thomas, Choidas, Axel, Daub, Henrik, Godl, Klaus
Format Journal Article
LanguageEnglish
Published England Oxford University Press 01.11.2003
Oxford Publishing Limited (England)
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Faced with the current wealth of genomic data, it is essential to have robust and reliable methods of converting DNA sequences into their functional gene products. We demonstrate here that when conditions are established that take advantage of the replication‐associated virus amplification, the virus‐induced shutdown of host protein synthesis as well as the activation of signalling pathways that normally occur during virus replication, adenovirus biology can be exploited to generate a potent kinase expression system. Residual virus in the protein production has always been a limitation for adenovirus systems and we describe a DNA intercalator/ultraviolet light treatment that eliminates residual adenovirus in protein preparations that has no deleterious effect on enzyme activity. The use of mammalian cells in combination with adenovirus generated a variety of active enzymes which could not be produced in Escherichia coli or baculovirus‐infected insect cells. Thus, the utility of adenovirus‐mediated enzyme expression as a versatile alternative to established protein production technologies is demonstrated.
Bibliography:To whom correspondence should be addressed. Tel: +49 89 550 65 472; Fax: +49 89 550 65 461; Email: matt.cotten@axxima.com
Received July 17, 2003; Revised and Accepted September 8, 2003
istex:D612E58ADDF453CE9187EB9C9167429B293DA1D7
ark:/67375/HXZ-GBX4LFZ8-1
local:gng128
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0305-1048
1362-4962
1362-4962
DOI:10.1093/nar/gng128